These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 23091501)

  • 61. Policy perspectives on the emerging pathways of personalized medicine.
    Downing GJ
    Dialogues Clin Neurosci; 2009; 11(4):377-87. PubMed ID: 20135895
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Challenges and opportunities in cardiovascular health informatics.
    Zhang YT; Zheng YL; Lin WH; Zhang HY; Zhou XL
    IEEE Trans Biomed Eng; 2013 Mar; 60(3):633-42. PubMed ID: 23380853
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Chronoastrobiology: proposal, nine conferences, heliogeomagnetics, transyears, near-weeks, near-decades, phylogenetic and ontogenetic memories.
    Halberg F; Cornélissen G; Regal P; Otsuka K; Wang Z; Katinas GS; Siegelova J; Homolka P; Prikryl P; Chibisov SM; Holley DC; Wendt HW; Bingham C; Palm SL; Sonkowsky RP; Sothern RB; Pales E; Mikulecky M; Tarquini R; Perfetto F; Salti R; Maggioni C; Jozsa R; Konradov AA; Kharlitskaya EV; Revillam M; Wan C; Herold M; Syutkina EV; Masalov AV; Faraone P; Singh RB; Singh RK; Kumar A; Singhs R; Sundaram S; Sarabandi T; Pantaleoni G; Watanabe Y; Kumagai Y; Gubin D; Uezono K; Olah A; Borer K; Kanabrockia EA; Bathina S; Haus E; Hillman D; Schwartzkopff O; Bakken EE; Zeman M
    Biomed Pharmacother; 2004 Oct; 58 Suppl 1():S150-87. PubMed ID: 15754855
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Personalized medicine: how much can we afford? A bioethics perspective.
    Lunshof J
    Per Med; 2005 Mar; 2(1):43-47. PubMed ID: 29793239
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Personalized Medicine in a New Genomic Era: Ethical and Legal Aspects.
    Shoaib M; Rameez MAM; Hussain SA; Madadin M; Menezes RG
    Sci Eng Ethics; 2017 Aug; 23(4):1207-1212. PubMed ID: 27896605
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The new era of personalized medicine: 10 years later.
    Jørgensen JT; Winther H
    Per Med; 2009 Jul; 6(4):423-428. PubMed ID: 29783540
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The ethical framing of personalized medicine.
    Joly Y; Saulnier KM; Osien G; Knoppers BM
    Curr Opin Allergy Clin Immunol; 2014 Oct; 14(5):404-8. PubMed ID: 25054830
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The Impact of Pharmacogenomics in Personalized Medicine.
    Singh DB
    Adv Biochem Eng Biotechnol; 2020; 171():369-394. PubMed ID: 31485703
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Making preventive medicine more personalized: implications for exercise-related research.
    Buford TW; Pahor M
    Prev Med; 2012 Jul; 55(1):34-6. PubMed ID: 22588227
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Personalized medicine is more than genomic medicine: confusion over terminology impedes progress towards personalized healthcare.
    Simmons LA; Dinan MA; Robinson TJ; Snyderman R
    Per Med; 2012 Jan; 9(1):85-91. PubMed ID: 29783292
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Personalized medicine and genomics: challenges and opportunities in assessing effectiveness, cost-effectiveness, and future research priorities.
    Conti R; Veenstra DL; Armstrong K; Lesko LJ; Grosse SD
    Med Decis Making; 2010; 30(3):328-40. PubMed ID: 20086232
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Computational challenges of personal genomics.
    Bolouri H
    Curr Genomics; 2008 Apr; 9(2):80-7. PubMed ID: 19440448
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Balancing personalized medicine and personalized care.
    Cornetta K; Brown CG
    Acad Med; 2013 Mar; 88(3):309-13. PubMed ID: 23348082
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Model-guided therapy for hepatocellular carcinoma: a role for information technology in predictive, preventive and personalized medicine.
    Berliner L; Lemke HU; vanSonnenberg E; Ashamalla H; Mattes MD; Dosik D; Hazin H; Shah S; Mohanty S; Verma S; Esposito G; Bargellini I; Battaglia V; Caramella D; Bartolozzi C; Morrison P
    EPMA J; 2014; 5(1):16. PubMed ID: 25538797
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Scientific-practical and legal problems of implementation of the personalized medicine.
    Bezdieniezhnykh NO; Reznikova VV; Rossylna OV
    Exp Oncol; 2017 Sep; 39(3):229-233. PubMed ID: 28967634
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Personalized medicine: reality and reality checks.
    Leeder JS; Spielberg SP
    Ann Pharmacother; 2009 May; 43(5):963-6. PubMed ID: 19417116
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Personalized medicine, privatized medicine? legal and public health stakes].
    Rial-Sebbag E
    Med Sci (Paris); 2014 Nov; 30 Spec No 2():36-40. PubMed ID: 25407457
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Personalized diagnostics and biosensors: a review of the biology and technology needed for personalized medicine.
    Ahmed MU; Saaem I; Wu PC; Brown AS
    Crit Rev Biotechnol; 2014 Jun; 34(2):180-96. PubMed ID: 23607309
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Personalized diagnostic and therapeutic strategies in oncology.
    Febbo PG; Ginsburg GS
    Per Med; 2005 May; 2(2):97-110. PubMed ID: 29788586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.